Literature DB >> 17579918

pH-responsive Multi-PEGylated dual cationic nanoparticles enable charge modulations for safe gene delivery.

May P Xiong1, Younsoo Bae, Shigeto Fukushima, M Laird Forrest, Nobuhiro Nishiyama, Kazunori Kataoka, Glen S Kwon.   

Abstract

In gene therapy, the cytotoxicity of many polycations is undesirable and has been attributed to nonspecific membrane destabilizing effects and intracellular polyplex-mediated toxicity. To help prolong the pharmacokinetic profile of nonviral vehicles for gene delivery, the cationic surface charge of current systems is typically shielded through the conjugation of polyethylene glycol (PEG) chains to the particle surface. However, the design of an intelligent polycation with environment-sensing charge modulations is essential to minimize cytotoxicity and enhance gene expression. We have designed a novel di-cationic block copolymer, poly(aspartate-hydrazide)-block-poly(L-lysine), capable of pH-mediated endosomal membrane disruption based on charge interactions, which has negligible toxicity elsewhere to the cell. The poly(L-lysine) segment, with a high pK(a) value of approximately 9.4, preferentially forms a poly-ion complex with the negative phosphate groups of pDNA, whereas the pH-responsive poly(aspartate-hydrazide) segment, with the comparatively lower pK(a) approximately 5.0, is characterized by a substantial fraction of unprotonated amino groups at physiological pH. As a consequence, complexation between such a polymer and pDNA leads to the formation of a two-layered nanoparticle. In particular, the nanoparticle possesses an unprotonated pH-responsive segment to serve as both a scaffold for acid-labile linkages of various moieties such as aldehyde-PEG and to transition from neutral to charged for disrupting endosomal membranes, and safely enhancing gene expression. Our system supports an endosomal escape mechanism based on charge interactions rather than the proton-sponge effect, and may be an important step towards engineering new classes of intelligent nonviral vectors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579918     DOI: 10.1002/cmdc.200700093

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  8 in total

Review 1.  Combinatorial approaches in post-polymerization modification for rational development of therapeutic delivery systems.

Authors:  Yuanbo Zhong; Brian J Zeberl; Xu Wang; Juntao Luo
Journal:  Acta Biomater       Date:  2018-04-12       Impact factor: 8.947

Review 2.  Well-defined cationic shell crosslinked nanoparticles for efficient delivery of DNA or peptide nucleic acids.

Authors:  Ke Zhang; Huafeng Fang; Gang Shen; John-Stephen A Taylor; Karen L Wooley
Journal:  Proc Am Thorac Soc       Date:  2009-08-15

3.  Stimuli responsive charge-switchable lipids: Capture and release of nucleic acids.

Authors:  Joseph S Hersey; Caroline M LaManna; Hrvoje Lusic; Mark W Grinstaff
Journal:  Chem Phys Lipids       Date:  2016-02-16       Impact factor: 3.329

4.  Altering amine basicities in biodegradable branched polycationic polymers for nonviral gene delivery.

Authors:  Sue Anne Chew; Michael C Hacker; Anita Saraf; Robert M Raphael; F Kurtis Kasper; Antonios G Mikos
Journal:  Biomacromolecules       Date:  2010-03-08       Impact factor: 6.988

5.  pH-sensitive multi-PEGylated block copolymer as a bioresponsive pDNA delivery vector.

Authors:  Tsz Chung Lai; Younsoo Bae; Takayuki Yoshida; Kazunori Kataoka; Glen S Kwon
Journal:  Pharm Res       Date:  2010-03-19       Impact factor: 4.200

6.  Histamine-functionalized copolymer micelles as a drug delivery system in 2D and 3D models of breast cancer.

Authors:  Yuning Zhang; Pontus Lundberg; Maren Diether; Christian Porsch; Caroline Janson; Nathaniel A Lynd; Cosimo Ducani; Michael Malkoch; Eva Malmström; Craig J Hawker; Andreas M Nyström
Journal:  J Mater Chem B       Date:  2015-03-28       Impact factor: 6.331

7.  Polycation-telodendrimer nanocomplexes for intracellular protein delivery.

Authors:  Xu Wang; Changying Shi; Lili Wang; Juntao Luo
Journal:  Colloids Surf B Biointerfaces       Date:  2017-12-12       Impact factor: 5.268

8.  Scope of nanotechnology in ovarian cancer therapeutics.

Authors:  Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  J Ovarian Res       Date:  2010-08-06       Impact factor: 4.234

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.